Samsung Proposes Offer to Acquire Swiss CDMO Specializing in Peptides
Samsung Biologics CEO, John Rim, says the PolyPeptide acquisition reinforces the company’s long-term growth strategy by not only…
CDMOs Expand and Build for Future Growth
Merck KGaA, Darmstadt, Germany—whose Life Sciences business in the U.S. and Canada is known as MilliporeSigma—is completing construction…